K253092

Substantially Equivalent

Argos Infinity (Rev. 1.0)

Applicant: Retia Medical Systems, Inc.
Product code: DXG
Advisory panel: Cardiovascular
Date received: 2025-09-23
Decision date: 2026-02-13
Decision: Substantially Equivalent
Clearance type: Traditional
Location: White Plains, NY, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.